Clinical Trials in San Diego

Showing 1461-1480 of 7,028 trials

Phase II Protocol of Proton Therapy for Partial Breast Irradiation in Early Stage Breast Cancer

NCT01766297

The purpose of this research study is to compare the effects (good and bad) on women and their cancer using proton radiation therapy. This study is being done to see if proton radiation therapy will prove to be beneficial for women with early stage breast cancer. A clinical study is necessary to compare the results (good or bad) of proton radiation therapy.

Breast CancerBreast NeoplasmBreast Tumor+1 more

Proton Collaborative Group132 participantsStarted Feb 2013

Scottsdale, Arizona, United States • San Diego, California, United States • Warrenville, Illinois, United States +6 more locations

Active Not RecruitingPhase 2< 1 mile

Nivolumab in Treating Patients With Persistent, Recurrent, or Metastatic Cervical Cancer

NCT02257528

This phase II trial studies the side effects and how well nivolumab works in treating patients with cervical cancer that has grown, come back, or spread to other places in the body. Monoclonal antibodies, such as nivolumab, may block tumor growth in different ways by targeting certain cells.

Cervical AdenocarcinomaCervical Adenosquamous CarcinomaRecurrent Cervical Carcinoma+3 more

National Cancer Institute (NCI)26 participantsStarted May 2015

Birmingham, Alabama, United States • Anchorage, Alaska, United States • Anchorage, Alaska, United States +330 more locations

Phase II Protocol of Proton Therapy for Partial Breast Irradiation in Early Stage Breast Cancer

Nivolumab in Treating Patients With Persistent, Recurrent, or Metastatic Cervical Cancer

Find Trials by Condition in San Diego

First-in-Human Study of OKI-219 in Advanced Solid Tumors and Advanced Breast Cancer

OCS DCD Heart + CAP Continued Follow-Up

A Study to Assess the Safety and Tolerability of BMS-986158 Alone and in Combination With Either Ruxolitinib or Fedratinib in Participants With Blood Cancer (Myelofibrosis)

S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis

A Trial of Centanafadine Efficacy, Safety, and Tolerability in Adult Subjects With Binge Eating Disorder

FebriDx® Method Comparison Study Protocol

Gla-300 and IDeg-100 in Insulin-Naïve People With Type 2 Diabetes Mellitus and Renal Impairment

Phase 2a Study of the Safety, Tolerability, and Pharmacokinetics of Topically Administered PRN473 (SAR444727) in Patients With Mild to Moderate Atopic Dermatitis

A Prospective, US-based Study Assessing Mogamulizumab-associated Rash in Patients Diagnosed With Mycosis Fungoides or Sezary Syndrome and Treated With Standard of Care Mogamulizumab

Study to Evaluate the Efficacy & Safety of the INTERCEPT Blood System for RBCs in Complex Cardiac Surgery Patients

Abatacept in Immune Checkpoint Inhibitor Myocarditis

A Study of Relatlimab Plus Nivolumab Versus Nivolumab Alone in Participants With Advanced Melanoma

A Study of LM-24C5 For Advanced Solid Tumors

A Study of Nemtabrutinib (MK-1026) in Participants With Relapsed or Refractory Hematologic Malignancies (ARQ 531-101/MK-1026-001)

Omalizumab as Monotherapy and as Adjunct Therapy to Multi-Allergen OIT in Food Allergic Participants

QuantifyHER: Quantitative Immunofluorescence and/or RT-qPCR for Measuring HER2 in HER2-low Metastatic Breast Cancer

OCS-01 in Treating Inflammation and Pain in Post-cataract Patients

Skin Reactions Related to Thoracic Implantable Chamber Dressings